Who Should Use Caution: Those with highly reactive skin or on prescription topical treatments should consult a dermatologist beforehand
Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials FDA warns about unapproved GLP-1 drugs online, calls for accessible trials The FDA has issued warnings about unapproved GLP-1 drugs circulating online - counterfeit, compounded, or mislabeled as research use only. When access to legitimate GLP-1 clinical trials is limited - by geography, logistics, or site capacity - progress slows
Second, if there is ongoing vomiting, dehydration, or quick weight loss, these are important signs to stop and review the dose with a doctor
Metabolic rate preservation matters for long-term success
This finding echoed what many women had already been noticing and sharing online: increased breakouts that began shortly after starting these medications